New test detected resistant bacteria rapidly, accurately
Evaluation of the Carba NP test found it to be a rapid, inexpensive and accurate means of detecting carbapenem-resistant Enterobacteriaceae, according to data presented at ICAAC 2014.
“Over the past decade, carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) have rapidly spread around the globe and are currently considered an urgent public health threat by the CDC,” Karim Morey, MS, of the Oregon State Public Health Lab, said in a press release. “Timely detection of CP-CRE is critical to patient care and infection control.”
The study evaluated 196 clinical Enterobacteriaceae through a Carba NP test performed using protocol previously published by the Mayo Clinic. Known isolates OXA-48 and OXA-181, which were initially Carba NP negative, were retested using a modified protocol with increased inoculum size in a reduced volume of lysis solution.
The test’s sensitivity and specificity was 92% and 100%, respectively. It detected all tested carbapenemase producers while detecting zero of five OXA-48 and OXA-181 strains. When the modified protocol was applied, all five strains were detected. The test, performed in triplicate with subsets tested by different analysts, was 100% reproducible and took an average of 2.5 hours.
“The Carba NP test is highly sensitive, specific and reproducible for the detection of carbapenemase production in a diverse group of Enterobacteriaceae collected from a region with low carbapenem-resistant Enterobacteriaceae prevalence.” the researchers concluded.
For more information:
Morey K. Abstract D-888. Presented at: 2014 Interscience Conference on Antimicrobial Agents and Chemotherapy; Sept. 5-9; Washington, D.C.
Disclosure: The researchers report no relevant financial disclosures.